Clinical Trial Update: Combination Nilotinib and Paclitaxel in Adults With Relapsed Solid Tumors [Phase 1]

View source ↗

Summary

This clinical trial update reports on a Phase 1 study evaluating the combination of nilotinib and paclitaxel in adults with relapsed solid tumors, and the trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• PACLITAXEL (PACLITAXEL)
• Tasigna (nilotinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Solid Tumors | Phase 1 | Status: COMPLETED